Clindamycin Phosphate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Clindamycin Phosphate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23036
Buy Now

Clindamycin Phosphate Prices June 2023

Product
Category Region Price
Clindamycin Phosphate Pharma API North America 148278 USD/MT
Clindamycin Phosphate Pharma API APAC 143367 USD/MT
Clindamycin Phosphate Pharma API Europe 149586 USD/MT


The price of clindamycin phosphate in North America for Q2 2023 reached 148278 USD/MT in December.

The price trend for clindamycin phosphate in Asia Pacific concluded at 143367 USD/MT in June 2023.

In Europe, clindamycin phosphate prices for Q2 2023, reached 149586 USD/MT.

Clindamycin Phosphate Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Clindamycin Phosphate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clindamycin phosphate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clindamycin phosphate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clindamycin Phosphate Price Trend

Clindamycin Phosphate Market Analysis

The global clindamycin phosphate market size reached US$ 789 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 1255.8 Million, at a projected CAGR of 5.30% during 2023-2032.

  • The rising prevalence of bacterial infections globally has significantly driven the demand for effective antibiotics like clindamycin phosphate. It is a strong antibiotic that is effective in treating bacterial infections and is in high demand, given the rise in cases of skin infections, respiratory tract infections, and other bacterial illnesses.
  • Moreover, the growing incidence of antibiotic resistance is another critical driver. Clindamycin Phosphate's efficacy against certain drug-resistant strains of bacteria makes it a valuable alternative when other antibiotics fail, thereby boosting its demand in the pharmaceutical market.
  • In addition, clindamycin phosphate is being used more often in dermatology, especially to treat acne vulgaris. As acne continues to be a prevalent skin condition affecting a large demographic, both teenagers and adults, the demand for topical formulations of clindamycin phosphate remains high. Moreover, the effectiveness of clindamycin in reducing Propionibacterium acnes and its anti-inflammatory properties make it a popular choice among dermatologists, aiding the market growth.
  • Besides this, the trend towards minimally invasive (MI) treatments has increased the use of topical antibiotics, which is contributing to the clindamycin Phosphate gels and creams.
  • Furthermore, the rise in surgical procedures worldwide is impelling the market growth since clindamycin phosphate is commonly used prophylactically to prevent postoperative infections, particularly in surgeries involving the abdomen, gynecology, and orthopedics. Clindamycin phosphate is widely used as a preventive measure because of factors such as an aging population and advances in medical procedures leading to an increase in surgeries.
  • Along with this, advancements in pharmaceutical formulations and delivery systems also contribute to the growth of the clindamycin phosphate market. Innovations such as extended-release formulations and improved topical delivery systems enhance the drug's effectiveness and patient compliance, making treatment more convenient and efficient. The creation of novel gel and lotion formulations that enhance the stability and absorption of clindamycin phosphate is providing an impetus to the market growth.

Clindamycin Phosphate News

The report covers the latest developments, updates, and trends impacting the global clindamycin phosphate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clindamycin phosphate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the clindamycin phosphate industry:

  • In October 2023, Bausch Health Companies Inc. and Ortho Dermatologics announced that the FDA has approved Cabtreo™ (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel will be available in Q1 2024. It is used for treating acne vulgaris in patients aged twelve and older, marking the first fixed-dose, triple-combination topical treatment approved for acne.

Product Description

Clindamycin phosphate is a semi-synthetic antibiotic from the lincosamide class, derived from lincomycin. It is frequently used to treat a range of bacterial infections, both topically and systemically. Clindamycin phosphate is available in multiple formulations, including oral capsules, intravenous injections, and topical gels, making it versatile in treating different types of infections.

The primary applications of clindamycin phosphate span across multiple medical fields due to its broad-spectrum antibacterial properties. It is particularly effective against anaerobic bacteria and certain protozoa, making it a valuable tool in treating infections that other antibiotics might not effectively address. In dermatology, it is widely used in topical formulations to treat acne vulgaris by reducing the population of Propionibacterium acnes on the skin and decreasing inflammation.

Another significant use is in the management of bone and joint infections, such as osteomyelitis. Clindamycin phosphate is a crucial drug in orthopedic treatments because of its capacity to permeate bone tissue, which allows it to reach the infection site and exert its antibacterial effects.

Regional Coverage

The report provides a detailed analysis of the clindamycin phosphate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends.

Global Clindamycin Phosphate Price

The report offers a holistic view of the global clindamycin phosphate pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Clindamycin Phosphate Price

European clindamycin phosphate prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed clindamycin phosphate price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Clindamycin Phosphate Price

The analysis of clindamycin phosphate prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on clindamycin phosphate prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Clindamycin Phosphate Price

The report explores the clindamycin phosphate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on clindamycin phosphate prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Clindamycin Phosphate Price

The clindamycin phosphate pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed clindamycin phosphate prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Clindamycin Phosphate Price

The analysis of clindamycin phosphate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Clindamycin Phosphate
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of clindamycin phosphate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting clindamycin phosphate price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the clindamycin phosphate industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Clindamycin Phosphate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More